Medicare Enrolled

Dr. Gerard Boghossian, D.P.M.

Podiatrist · Lancaster, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
42135 10TH ST W, Lancaster, CA 93534
6617265005
In practice since 2006 (20 years)
NPI: 1942263322 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Boghossian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Boghossian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Boghossian

Dr. Gerard Boghossian is a podiatrist in Lancaster, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Boghossian performed 900 Medicare services across 371 unique beneficiaries.

Between the years covered by Open Payments, Dr. Boghossian received a total of $49,819 from 22 pharmaceutical and/or device companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in podiatrist. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Boghossian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 900 Medicare services $49,819 industry payments

Medicare Practice Summary

Medicare Utilization ↗
900
Medicare services
Bottom 39% in CA for podiatrist
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
371
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~45 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
350 $73 $150
Skin and tissue removal, 20 sq cm or less
This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller.
180 $113 $223
Muscle or tissue removal, 20 sq cm or less
This procedure involves the surgical removal of muscle or other tissue from the body. The total area of the removed tissue is 20.0 square centimeters or less.
119 $197 $390
Foot X-ray, 3+ views
An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints.
87 $27 $60
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
65 $72 $185
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $104 $211
Ankle or foot strapping
Application of supportive bandages or tape to the ankle or foot to provide stability and protection.
37 $13 $47
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
24 $129 $274
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$49,819
Total received (2018-2024)
Avg $7,117/year across 7 years
Top 2% in CA for podiatrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
240
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$46,410 (93.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,410 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,205
2023
$3,962
2022
$357
2021
$7,764
2020
$6,350
2019
$6,606
2018
$23,577

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Paragon 28, Inc.
$642
Urgo Medical North America, LLC
$246
Paratek Pharmaceuticals, Inc.
$225
Bioventus LLC
$50
BIOTISSUE HOLDINGS INC.
$22
Smith+Nephew, Inc.
$20
Top 3 companies account for 92.3% of 2024 payments
All-time payments by company (2018-2024) ›
Smith & Nephew, Inc.
$23,467
Smith+Nephew, Inc.
$23,028
Paragon 28, Inc.
$1,359
Paratek Pharmaceuticals, Inc.
$708
Urgo Medical North America, LLC
$246
Horizon Therapeutics plc
$193
DePuy Synthes Sales Inc.
$183
Organogenesis Inc.
$125
TREACE MEDICAL CONCEPTS, INC.
$80
Osiris Therapeutics Inc.
$71
Bioventus LLC
$66
Next Science LLC
$38
Integra LifeSciences Corporation
$36
KCI USA, Inc.
$35
Gilead Sciences, Inc.
$32
Melinta Therapeutics, Inc.
$27
Forte Bio-Pharma LLC
$25
SPR Therapeutics, Inc
$23
BIOTISSUE HOLDINGS INC.
$22
Nabriva Therapeutics, plc
$19
Advanced Oxygen Therapy Inc.
$19
GlaxoSmithKline, LLC.
$16
Top 3 companies account for 96.1% of all-time payments
Associated products mentioned in payments ›
ACTIV.A.C. · Apex 3D · BME NITINOL CONTINUOUS COMPRESSION IMPLANTS · Baxdela · COLLAGENASE SANTYL · DUEXIS · EXOGEN ULTRASOUND BONE HEALING SYSTEM · Exogen Ultrasound Bone Healing System · FIBERGRAFT · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · HAMMERLOCK · HEADLESS COMPRESSION SCREWS · HEALIX · Integra · Iodosorb · LAPIPLASTY SYSTEM · NUZYRA · Nalocet · Oasis · PICO · Portfolio · Puraply Antimicrobial · REGRANEX · Regranex · SPEED · SPRINT PNS System · SURGX · Santyl · Sivextro · TRELEGY ELLIPTA · Trodelvy · URGOK2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in podiatrist and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for podiatrist in CA.

Looking for a podiatrist in Lancaster?
Compare podiatrists in the Lancaster area by procedure volume, costs, and industry payment transparency.
Browse podiatrists nearby

Geographic Context

Podiatrists within 10 mi
7
Per 100K population
0.1
County median income
$87,760
Nearest hospital
ANTELOPE VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Boghossian is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Boghossian experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Boghossian performed 350 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Boghossian receive payments from pharmaceutical companies?
Yes. Dr. Boghossian received a total of $49,819 from 22 companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Boghossian's costs compare to other podiatrists in Lancaster?
Dr. Boghossian's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Boghossian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →